| Literature DB >> 35774503 |
Xuehua Xie1,2,3,4,5,6, Yu Han1,2,3,4,5,6, Xi Yuan1,2,3,4,5,6, Man Zhang1,2,3,4,5,6, Ping Li1,2,3,4,5,6, Aiqin Ding1,2,3,4,5,6, Jia Wang1,2,3,4,5,6, Tangren Cheng1,2,3,4,5,6, Qixiang Zhang1,2,3,4,5,6.
Abstract
Leaf blight, caused by Botrytis elliptica (Berk.) Cooke, is a devastating disease that limits the production of Lilium in China and in other countries worldwide. Numerous studies have indicated that plants have evolved sophisticated and effective signal transduction and defense-related pathways in response to pathogen invasion. Recently, particular attention has been given to the action(s) of melatonin in plants in response to biotic stress, and the role of melatonin in plant-pathogen interactions has also been discussed. In this study, RNA-seq was applied to analyze the transcriptomic changes in Lilium leaves that were pre-treated and post-treated with melatonin after B. elliptica infection for 0, 12, 24, 36, and 72 h and then compare those changes with those of the control. Treatment with exogenous melatonin and infection with B. elliptica caused differential expression of a large number of genes in Lilium leaves. KEGG pathway analysis showed that, after melatonin treatment, the defense-related DEGs were mainly enriched in plant-pathogen interactions, plant hormone signal transduction, MAPK signaling pathways, phenylpropanoid biosynthesis, and phenylalanine metabolism. RT-qPCR was used to verify the expression changes of 12 DEGs, the results of which were consistent with the RNA-seq analysis results. The expression of DEGs related to the MAPK pathway were significantly different between the MB group and the HB group, suggesting that, via the MAPK signaling cascade, melatonin may play a role in the disease resistance of Lilium to B. elliptica. This study provides a new perspective and information for molecular-based breeding of Lilium disease resistance.Entities:
Keywords: Botrytis elliptica; MAPK cascades; disease resistance; melatonin; transcriptome analysis
Year: 2022 PMID: 35774503 PMCID: PMC9237519 DOI: 10.3389/fgene.2022.892674
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
FIGURE 1Effect of exogenous melatonin pre-treatment on Lilium resistance to B. elliptica. (A) Effect of melatonin concentration on disease index at 36 h for plants pretreated with 0, 0.02, 0.2, 2 or 20 mM melatonin. MEL6d represents plants were pre-treatment with melatonin for 6 days (once every 2 days), MEL10d represents plants were pre-treatment with melatonin for 10 days (once every 2 days). (B) Effect of melatonin concentration on disease index at 72 h for plants pretreated with 0, 0.02, 0.2, 2 or 20 mM melatonin. MEL6d represents plants were pre-treatment with melatonin for 6 days (once every 2 days), MEL10d represents plants were pre-treatment with melatonin for 10 days (once every 2 days). (C) Effect of melatonin concentration on disease index at 120 h for plants pretreated with 0, 0.02, 0.2, 2 or 20 mM melatonin. MEL6d represents plants were pre-treatment with melatonin for 6 days (once every 2 days), MEL10d represents plants were pre-treatment with melatonin for 10 days (once every 2 days). (D) Effect of exogenous melatonin pre-treatment on Phenylalanine ammonia lyase (PAL) activity of Lilium after inoculation. MB represents plants were pre-treatment with 2 mM melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. (E) Effect of exogenous melatonin pre-treatment on catalase (CAT) activity of Lilium after inoculation. MB represents plants were pre-treatment with 2 mM melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. Data represent mean ± SE of triplicate assays. The line charts were generated based on IBM SPSS Statistics 20. The “*” represents the significant differences.
FIGURE 2Differentially expressed genes statistics between melatonin treatment group and control group. (A) Upregulated and down regulated DEGs (padj < 0.05) statistics of MB group vs. HB group at five points in time after inoculation. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. (B) Venn diagram of the number of DEGs (padj < 0.05) between MB group vs. HB group. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. (C) Volcano plot of DEGs (padj < 0.05) between the comparison BEM vs. BEH, BEM represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml melatonin (2 mM/L) for 36 h; BEH represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml Milli-Q water [ethanol/water (v/v). D 1/10,000] for 36 h. (D) Venn diagram illustrate the number of DEGs (padj < 0.05) between the comparison BEM vs. BEH, BEM represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml melatonin (2 mM/L) for 36 h; BEH represents plants were inoculated with B. elliptica 36 h and then treated with 100 ml Milli-Q water [ethanol/water (v/v) D 1/10,000] for 36 h.
FIGURE 3Differentially expressed genes statistics at different time point’s comparison. (A) Number of up regulated and down regulated DEGs (padj < 0.05) statistics for four comparisons (12 vs. 0 h; 24 vs. 0 h; 36 vs. 0 h; 72 vs. 0 h) in MB group and HB group. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. (B) Venn diagram illustrate the number of DEGs in four comparisons (12 vs. 0 h; 24 vs. 0 h; 36 vs. 0 h; 72 vs. 0 h) overlapping in MB group, MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; (C) Venn diagram illustrate the number of DEGs in four comparisons (12 vs. 0 h; 24 vs. 0 h; 36 vs. 0 h; 72 vs. 0 h) overlapping in HB group, HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica; (D) Number of up regulated and down regulated DEGs (padj < 0.05) statistics for four comparisons (12 vs. 0 h; 24 vs. 12 h; 36 vs. 24 h; 72 vs. 36 h) in MB group and HB group. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. (E) Venn diagram illustrate the number of DEGs in four comparisons (12 vs. 0 h; 24 vs. 12 h; 36 vs. 24 h; 72 vs. 36 h) overlapping in MB group, MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica. (F) Venn diagram illustrate the number of DEGs in four comparisons (12 vs. 0 h; 24 vs. 12 h; 36 vs. 24 h; 72 vs. 36 h) overlapping in HB group, HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica.
FIGURE 4Differential gene expression profiles involved in plant-pathogen interaction pathway, phenylpropanoid biosynthesis pathway, SA and JA signaling pathway during B. elliptica infection. (A) Gene expression profiles in plant-pathogen interaction pathway. (B) Gene expression profiles in phenylpropanoid biosynthesis pathway. (C) Gene expression profiles in SA and JA signaling pathway. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. BEM represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml melatonin (2 mM/L) for 36 h; BEH represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml Milli-Q water [ethanol/water (v/v) D 1/10,000] for 36 h.
FIGURE 5Differential gene expression profiles involved in MAPK Signaling pathway. MB represents plants were pre-treatment with melatonin and then inoculated with B. elliptica; HB represents plants were pre-treatment with Milli-Q water [ethanol/water (v/v) D 1/10,000], and then inoculated with B. elliptica. BEM represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml melatonin (2 mM/L) for 36 h; BEH represents plants were inoculated with B. elliptica for 36 h and then treated with 100 ml Milli-Q water [ethanol/water (v/v) D 1/10,000] for 36 h.
FIGURE 6Potential model illustrating the melatonin induced defense signaling in Lilium against B. elliptica. B. elliptica infection or exogenous melatonin application induced activation of MAPK cascades and NO accumulation, which in turn activates defense related genes. Abbreviation: ROS, reactive oxygen species; MAPK, Mitogen-activated protein kinase; NO, nitric oxide; SA, salicylic acid; JA, jasmonic acid; M, melatonin.